357 related articles for article (PubMed ID: 26331711)
1. Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and tumor location: Multicenter randomized trial.
Yoshizawa Y; Sugimoto M; Sato Y; Sahara S; Ichikawa H; Kagami T; Hosoda Y; Kimata M; Tamura S; Kobayashi Y; Osawa S; Sugimoto K; Miyajima H; Furuta T
Dig Endosc; 2016 Mar; 28(2):162-72. PubMed ID: 26331711
[TBL] [Abstract][Full Text] [Related]
2. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
[TBL] [Abstract][Full Text] [Related]
3. The effect of early Helicobacter pylori eradication on the healing of ESD-induced artificial ulcers: A retrospective study.
Song WC; Wang XF; Lv WW; Xu XY; Tian M
Medicine (Baltimore); 2019 May; 98(22):e15807. PubMed ID: 31145312
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori eradication on iatrogenic ulcer by endoscopic resection of gastric tumour: a prospective, randomized, placebo-controlled multi-centre trial.
Kim SG; Song HJ; Choi IJ; Cho WY; Lee JH; Keum B; Lee YC; Kim JG; Park SK; Park BJ; Jung HC;
Dig Liver Dis; 2013 May; 45(5):385-9. PubMed ID: 23333104
[TBL] [Abstract][Full Text] [Related]
5. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori eradication therapy may facilitate gastric ulcer healing after endoscopic mucosal resection: a prospective randomized study.
Cheon JH; Kim JH; Lee SK; Kim TI; Kim WH; Lee YC
Helicobacter; 2008 Dec; 13(6):564-71. PubMed ID: 19166423
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori status and the extent of gastric atrophy do not affect ulcer healing after endoscopic submucosal dissection.
Kakushima N; Fujishiro M; Yahagi N; Kodashima S; Nakamura M; Omata M
J Gastroenterol Hepatol; 2006 Oct; 21(10):1586-9. PubMed ID: 16928221
[TBL] [Abstract][Full Text] [Related]
8. Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy.
Sugimoto M; Furuta T; Shirai N; Ikuma M; Hishida A; Ishizaki T
Clin Pharmacol Ther; 2006 Jul; 80(1):41-50. PubMed ID: 16815316
[TBL] [Abstract][Full Text] [Related]
9. First-line eradication for Helicobacter pylori-positive gastritis by esomeprazole-based triple therapy is influenced by CYP2C19 genotype.
Saito Y; Serizawa H; Kato Y; Nakano M; Nakamura M; Saito H; Suzuki H; Kanai T
World J Gastroenterol; 2015 Dec; 21(48):13548-54. PubMed ID: 26730167
[TBL] [Abstract][Full Text] [Related]
10. Effect of MDR1 C3435T polymorphism on cure rates of Helicobacter pylori infection by triple therapy with lansoprazole, amoxicillin and clarithromycin in relation to CYP 2C19 genotypes and 23S rRNA genotypes of H. pylori.
Furuta T; Sugimoto M; Shirai N; Matsushita F; Nakajima H; Kumagai J; Senoo K; Kodaira C; Nishino M; Yamade M; Ikuma M; Watanabe H; Umemura K; Ishizaki T; Hishida A
Aliment Pharmacol Ther; 2007 Sep; 26(5):693-703. PubMed ID: 17697203
[TBL] [Abstract][Full Text] [Related]
11. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of Helicobacter pylori eradication therapy immediately after endoscopic submucosal dissection.
Takahashi Y; Takeuchi T; Kojima Y; Nagami Y; Ominami M; Uedo N; Hamada K; Suzuki H; Oda I; Miyaoka Y; Yamanouchi S; Tokioka S; Tomatsuri N; Yoshida N; Naito Y; Nonaka T; Kodashima S; Ogata S; Hongo Y; Oshima T; Li Z; Shibagaki K; Oikawa T; Tominaga K; Higuchi K
J Gastroenterol Hepatol; 2018 Jul; 33(7):1341-1346. PubMed ID: 29265496
[TBL] [Abstract][Full Text] [Related]
13. Association between
Kim SB; Lee SH; Bae SI; Jeong YH; Sohn SH; Kim KO; Jang BI; Kim TN
World J Gastroenterol; 2016 Nov; 22(44):9794-9802. PubMed ID: 27956803
[TBL] [Abstract][Full Text] [Related]
14. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.
Fukase K; Kato M; Kikuchi S; Inoue K; Uemura N; Okamoto S; Terao S; Amagai K; Hayashi S; Asaka M;
Lancet; 2008 Aug; 372(9636):392-7. PubMed ID: 18675689
[TBL] [Abstract][Full Text] [Related]
15. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
[TBL] [Abstract][Full Text] [Related]
16. Concomitant dosing of famotidine with a triple therapy increases the cure rates of Helicobacter pylori infections in patients with the homozygous extensive metabolizer genotype of CYP2C19.
Okudaira K; Furuta T; Shirai N; Sugimoto M; Miura S
Aliment Pharmacol Ther; 2005 Feb; 21(4):491-7. PubMed ID: 15710002
[TBL] [Abstract][Full Text] [Related]
17. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
[TBL] [Abstract][Full Text] [Related]
18. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection.
Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Inaba T; Yamamoto K; Okada H; Yokota K; Oguma K; Shiratori Y
Am J Gastroenterol; 2003 Nov; 98(11):2403-8. PubMed ID: 14638340
[TBL] [Abstract][Full Text] [Related]
20. High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin.
Furuta T; Shirai N; Xiao F; Takashita M; Sugimoto M; Kajimura M; Ohashi K; Ishizaki T
Hepatogastroenterology; 2003; 50(54):2274-8. PubMed ID: 14696516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
